APA (7th ed.) Citation

Barbarash, O. L., Fedorova, N. V., Sedykh, D. Y., Gruzdeva, O. V., Khryachkova, O. N., Kashtalap, V. V., & Filimonova, A. A. (2020). PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders. «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Barbarash, O. L., N. V. Fedorova, D. Yu Sedykh, O. V. Gruzdeva, O. N. Khryachkova, V. V. Kashtalap, and A. A. Filimonova. PCSK9 Inhibitors for In-hospital Treatment of Patients with Acute Coronary Syndrome and Severe Lipid Metabolism Disorders. «FIRMA «SILICEA» LLC, 2020.

MLA (9th ed.) Citation

Barbarash, O. L., et al. PCSK9 Inhibitors for In-hospital Treatment of Patients with Acute Coronary Syndrome and Severe Lipid Metabolism Disorders. «FIRMA «SILICEA» LLC, 2020.